EUVIMEDEUVIMED entdecken
Kohortenstudie

Long-term treatment with lithium, valproate, and atypical antipsychotics on suicide risk in patients with bipolar disorder: A nationwide retrospective cohort study

Sol A Park, Serhim Son, Bum Sik Tae, Hangseok Choi, Jong-Hyun Jeong, Ho-Kyoung Yoon, Cheolmin Shin, Do-Young Kwon, Young-Hoon Ko

Journal of Affective Disorders · 2026

DOI: 10.1016/j.jad.2025.120264 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Sol A Park und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea. Hauptthemen laut MEDLINE: Bipolar Disorder, Antipsychotic Agents, Valproic Acid, Suicide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Korea University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with bipolar disorder exhibit higher suicide and mortality rates than the general population, owing to suicidal behaviors. This study examined the long-term effects of lithium, valproate, and atypical antipsychotics on suicide attempts and suicides among Korean patients with bipolar disorder. METHODS: This retrospective study used Korean healthcare claims data of 44,694 individuals (mean age 31.09 ± 9.81 years; 58.07 % female) with at least two principal diagnoses of bipolar disorder and at least two prescriptions for lithium, valproate, carbamazepine, or atypical antipsychotics (risperidone, quetiapine, olanzapine, aripiprazole, and ziprasidone) between 2002 and 2020. We examined the risk of suicide attempts and suicide during the period with each drug using Cox proportional regression. RESULTS: The risk of suicide incidents decreased by 39.2 % and 26.0 % during treatment with lithium alone (hazard ratio [HR] 0.608, 95 % confidence interval [CI] 0.434-0.852) and valproate alone (HR 0.740, 95 % CI 0.577-0.949), respectively, compared to that without lithium, valproate, or atypical antipsychotics. In the within-individual analysis, the HR for suicide incidents was 0.154 during treatment with lithium and atypical antipsychotics (95 % CI 0.055-0.428). When lithium, valproate, and atypical antipsychotics were combined, the HR was 0.235 (95 % CI 0.056-0.980). The HRs were 0.251 (95 % CI 0.090-0.698) for valproate alone and 0.302 (95 % CI 0.152-0.599) for valproate in combination with atypical antipsychotics. CONCLUSIONS: Suicide risk decreased during treatment with lithium or valproate alone. In patients with bipolar disorder who are at a high risk of suicide, atypical antipsychotics were associated with a reduced risk of suicide when combined with lithium or valproate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderAntipsychotic AgentsValproic AcidSuicideSuicide, AttemptedLithium CompoundsAntimanic AgentsHumansFemaleMaleRetrospective StudiesAdultRepublic of KoreaMiddle AgedYoung Adult

Stichwörter der Autor:innen

Atypical antipsychoticsBipolar disorderMood stabilizersSuicide risk

Substanzen

Antipsychotic AgentsValproic AcidLithium CompoundsAntimanic Agents

Autor:innen und Institutionen

  • Department of Psychiatry, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.
  • Department of Biostatistics, College of Medicine, Korea University, Seoul, Republic of Korea.
  • Department of Urology, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.
  • Medical Science Research Center, Korea University College of Medicine, Seoul, Republic of Korea.
  • Department of Psychiatry, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Republic of Korea.
  • Department of Neurology, Center for Movement Disorders and Neurodegenerative Diseases, Korea University Ansan Hospital, Ansan, Republic of Korea.

Förderung

  • Korea University

Zitieren

APA

Park, S. A., Son, S., Tae, B. S., Choi, H., Jeong, J. H., Yoon, H. K., Shin, C., Kwon, D. Y., & Ko, Y. H. (2026). Long-term treatment with lithium, valproate, and atypical antipsychotics on suicide risk in patients with bipolar disorder: A nationwide retrospective cohort study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.120264

Vancouver

Park SA, Son S, Tae BS, Choi H, Jeong JH, Yoon HK, et al. Long-term treatment with lithium, valproate, and atypical antipsychotics on suicide risk in patients with bipolar disorder: A nationwide retrospective cohort study. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2025.120264

BibTeX
@article{Park2026,
  author = {Park, Sol A and Son, Serhim and Tae, Bum Sik and Choi, Hangseok and Jeong, Jong-Hyun and Yoon, Ho-Kyoung and Shin, Cheolmin and Kwon, Do-Young and Ko, Young-Hoon},
  title = {Long-term treatment with lithium, valproate, and atypical antipsychotics on suicide risk in patients with bipolar disorder: A nationwide retrospective cohort study},
  journal = {Journal of Affective Disorders},
  year = {2026},
  doi = {10.1016/j.jad.2025.120264}
}
Kostenlos starten →